Sustained notch signaling inhibition with a gamma-secretase inhibitor prevents traumatic heterotopic ossification

Zheng Wang; Xinzeyu Yi; Chao Jian; Baiwen Qi; Qiaoyun Liu; Zonghuan Li; Aixi Yu

doi:10.1016/j.jot.2023.06.004

Sustained notch signaling inhibition with a gamma-secretase inhibitor prevents traumatic heterotopic ossification

J Orthop Translat. 2023 Aug 1:42:31-42. doi: 10.1016/j.jot.2023.06.004. eCollection 2023 Sep.

Authors

Zheng Wang^{1

2}, Xinzeyu Yi^{1

2}, Chao Jian^{1

2}, Baiwen Qi^{1

2}, Qiaoyun Liu^{1

2}, Zonghuan Li^{1

2}, Aixi Yu^{1

2}

Affiliations

¹ Department of Orthopedics Trauma and Microsurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
² Hubei Clinical Medical Research Center of Trauma and Microsurgery, Wuhan, Hubei, China.

Abstract

Background: Traumatic heterotopic ossification (THO) is a devastating sequela following traumatic injuries and orthopedic surgeries. To date, the exact molecular mechanism of THO formation is still unclear, which hinders the development of effective treatments. The process of THO formation is believed to recapitulate a series of spatiotemporal cellular and signaling events that occur during skeletal development. The Notch signaling pathway is a critical genetic regulator in embryological bone development and fracture healing. However, few data are available concerning whether Notch signaling regulates THO development and maturation.

Methods: We firstly detected the expressions of Notch target genes in both mouse and human THO samples with quantitative RT-PCR and immunohistochemistry (IHC). Then, tissue-resident mesenchymal progenitor cells (TMPCs) were isolated, and the abilities of the proliferation and osteogenic and chondrogenic differentiation of TMPCs were examined under the intervention of the gamma-secretase inhibitor-DAPT at different time points. Finally, DAPT was also administrated in THO mice by burn and Achilles tenotomy injury, and ectopic cartilage and bone formation were monitored by histology and micro-CT.

Results: Several Notch target genes were upregulated in both mouse and human THO tissues. Sustained Notch signaling inhibition by DAPT reduced proliferation, osteogenic and chondrogenic differentiation of TMPCs in a time-dependent manner. Moreover, DAPT administration within 3 weeks could inhibit ectopic cartilage and bone formation in a mouse THO model without affecting the total body bone mass.

Conclusions: The Notch signaling serves as an important therapeutic target during THO formation. And sustained gamma-secretase inhibition by DAPT has great potential in repressing chondrogenic and osteogenic differentiation of TMPCs, as well as inhibited ectopic cartilage and bone formation in vivo.

The translational potential of this article: Sustained Notch inhibition via systemic DAPT (or other similar gamma-secretase inhibitors) administration has promising clinical utility for inhibiting THO formation, providing new insight into THO prophylaxis and treatment.

Keywords: Differentiation; Gamma-secretase; Notch signaling; Proliferation; Tissue-resident mesenchymal progenitor cells; Traumatic heterotopic ossification.